AADE Position Statement

American Association of Diabetes Educators. Prevention of transmission of blood-borne infectious agents during blood glucose monitoring. Diabetes Educ 1988;14:425-26.

Centers for Disease Control and Prevention. Recommendations for prevention of HIV transmission in healthcare settings. MMWR 1987; 36(2S):3S-18S.

Centers for Disease Control and Prevention. Update: universal precautions for prevention of transmission of human immunodeficiency virus. hepatitis B virus, and other bloodborne pathogens in healthcare settings. MMWR 1988:37(24): 378-88.

Centers for Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to healthcare and public safety workers. MMWR 1989:38(S-6):3-37.

Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures . MMWR 1991:40(RR-8):1-9.

Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood — France. United Kingdom. and United States, January, 1988 — August, 1994. MMWR 1995;44:929-33.

Alter MJ Margolis HS Krzysztof K. et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992:327: 1899-1905.

Lasker RD The Diabetes Control and Complications Trial: putting prevention into practice under health care reform. Diabetes Rev 1994 ; 2:350-58.

Engelgau MM , Aubert RE , Thompson TJ Herman WH Screening for NIDDM in nonpregnant adults. Diabetes Care 1995;18:1606-18.

Turnberg WL , Lowen LD Home syringe disposal: practice and policy in Washington state. Diabetes Educ 1994;20:489-92.

Satterfield D. Kling J. Diabetes educators encourage safe needle practice . Diabetes Educ 1991; 17(4):321-25.

American Association of Diabetes Educators. AADE guidelines. Infection control guidelines for patient education as a means or preventing bloodborne disease transmission during diabetes selfcarc procedures. Diabetes Educ 1991;17(4):259.

Siegel J. Teaching infection control in blood glucose monitoring. Diabetes Educ 1993;19(6): 489-95.

Gerherding JL Management of occupational exposures to bloodborne viruses. N Eng J Med 1995;332:444-51.

Polish LB , Shapiro CN Bauer F. et al. Nosocomial transmission of hepatitis B virus associated with spring-loaded finger stick device/California. N Engl J Med 1992;326:721-25.

Douvin C. Simon D. , Zinelabidine H. An outbrcak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device [Letter]. N Engl J Med 1990;322:57-58.

Food and Drug Administration. FDA safety alert: hepatitis B transmission via spring-loaded lancet devices. Rockville, Md: Food and Drug Administration. FDA Safety Alert, 1990 Aug 28.

Shalit P. , Brennan C. Murphy V. Hooton TM Risk of cross-infection through shared diabetic devices [Letter]. JAMA 1990;263:34-35.

Department of Labor. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: final rule. 29 CFR Part 1910.1030. Title 29, Federal Register 1991;56:64175-82.

Environmental Protection Agency. Disposal tips for home health care. Washington, DC: Environmental Protection Agency, Jan 1990: publication no. EPA/530-SW-90-014A.

Patton A. Your syringe is medical waste. Diabetes Forecast 1990;(Oct):27-30.